Influence of perfusate temperature on nasal potential difference

Abstract

Nasal potential difference (NPD) quantifies abnormal ion transport in cystic fibrosis. It has gained acceptance as an outcome measure for the investigation of new therapies.To quantify the effect of solution temperature on NPD, we first examined the effect of switching from room temperature (20-25uC) to warmed (32-37uC) solutions and vice versa during each perfusion step. Secondly, standard protocols were repeated at both temperatures in the same subjects.Changing solution temperature did not alter NPD during perfusion with Ringer's solution (,1 mV) (p.0.1). During perfusion with zero chloride solution, changing from room temperature to warmed solutions tended to decrease absolute NPD (i.e. it became less negative) by 0.9 mV (p.0.1); changing from warmed to room temperature increased NPD by 2.1 mV (p,0.05). During isoprenaline perfusion, changing from room temperature to warmed solutions increased NPD by 1.5 mV (p,0.01) and from warmed to room temperature decreased NPD by 1.4 mV (p,0.05).For full protocols at room temperature or warmed in the same subjects, mean values were similar (n524). During warmed perfusion, group results for total chloride response had a larger standard deviation. As this increased variability will probably decrease the power of trials, this study suggests that solutions at room temperature should be recommended for the measurement of NPD. @ERSpublications This study recommends that perfusate solutions for measuring nasal potential difference should be at room temperature

Nasal potential difference measurements in diagnosis of cystic fibrosis: An international survey

“…In contrast to the Table 1 Details of the provided NPD tracings (numbers in mV; Δ: response; Cl: chloride; CF: CF reference range; bold: CF range; scored by the centre of Giessen/Germany). [26] nor location of measurement [27]. To date most centres use the research CFF-TDN-SOP for diagnostic purposes.…”

Ivacaftor treatment in patients with cystic fibrosis and theG551D-CFTRmutation

“…Secondary end-points included improvements in CFTR-mediated ion transport (measured by nasal potential difference and sweat chloride concentrations) [15], pulmonary status (measured by forced expiratory volume in 1 s (FEV1)) and health-related quality of life (measured by the Cystic Fibrosis Questionnairerevised (CFQ-R)). The study was conducted in 10 CF patients who were o18 yrs and who had at least one copy of the G551D mutation as well as an FEV1 o40% [16].…”

Ocular Surface Potential Difference Measured in Human Subjects to Study Ocular Surface Ion Transport

“…Each syringe contained a different perfusion solution at room temperature, which has been shown to produce reliable results in nasal potential difference studies. 15 A three-way stopcock was used to connect the perfusion, measuring electrode, and multiport tubing. The perfusion system was flushed in reverse, starting with solution 5 and ending with solution 1.…”